Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-10-26
2009-10-06
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S279100
Reexamination Certificate
active
07598274
ABSTRACT:
Compounds of the formula (I), in which X, Y, Z and Ar have the meanings indicated in claim1, are inhibitors of Raf kinase and can be employed, inter alia, for the treatment of tumours
REFERENCES:
patent: 2004/0138269 (2004-07-01), Sun et al.
patent: 2004/0254186 (2004-12-01), Dean et al.
patent: 2008/0234270 (2008-09-01), Bannen et al.
patent: WO 03022833 (2003-03-01), None
Vippagunta et al., Crystalline solids, 2001, Advanced Drug Delivery Reviews, 48, pp. 3 and 18.
Wolff et al., Burger's Medicinal Chemistry and Drug Discovery, 1994, Wiley-lnterscience, Fifth Edition, vol. I: Principles and Practice, pp. 975-977.
Amendt Christiane
Buchstaller Hans-Peter
Burgdorf Lars
Finsinger Dirk
Grell Matthias
Bianchi Kristin
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Saeed Kamal A
LandOfFree
Pyrrole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4099824